Author

Yu Bao Zheng

Observed name: Yu Zheng

Institution: Dalian University

Observed institutions: Sun Yat-sen University, Dalian University, Third Affiliated Hospital of Sun Yat-sen University, University College London

ORCID: 0009-0005-0440-9633

Observed ORCID: 0009-0005-0440-9633

OpenAlex ID: A5109394201

Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

2020 · Cornelius Engelmann, Mohammed Sheikh, et al. · Journal of Hepatology · 182

Cell death markers in patients with cirrhosis and acute decompensation

2017 · Stewart Macdonald, Fausto Andreola, et al. · Hepatology · 99

Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect

2025 · Tian-Wang Zhu, Yu Zheng, et al. · PLoS ONE · 5

The neutrophil‐to‐lymphocyte ratio represents a systemic inflammation marker and reflects the relationship with 90‐day mortality in non‐cirrhotic chronic severe hepatitis

2022 · Fu Chen Dong, Wen Ting Tan, et al. · Journal of Digestive Diseases · 4

[Comparison of short- and long-term efficacy of three procedures in postoperative digestive tract reconstruction for upper gastric cancer].

2014 · Changqing Zeng, Liangxiang Huang, et al. · PubMed · 2

Correction: Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect

2025 · Tian-Wang Zhu, Yu Zheng, et al. · PLoS ONE · 1

Synthesis and antitumor activities of 5-carbohydrate modified cyclophosphamide derivates

2010 · Yu Zheng, Qing Li · Journal of Chinese Pharmaceutical Sciences

Works count: 7

Citation count: 293

H-index: 4

I10-index: 2